Abstract
The vasculitides are a heterogeneous group of conditions typified by their ability to cause vessel inflammation with or without necrosis. They present with a wide variety of signs and symptoms and, if left untreated, carry a significant burden of mortality and morbidity. The ANCA-associated vasculitides (AAV) are three separate conditions - granulomatosis with polyangiitis (GPA - formerly known as Wegener’s granulomatosis); microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA - previously known as Churg-Strauss Syndrome). This review examines recent developments in the pathogenesis and treatment of AAV.
Original language | English |
---|---|
Pages (from-to) | 60-64 |
Number of pages | 5 |
Journal | Clinical Medicine |
Volume | 17 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Feb 2017 |